110 related articles for article (PubMed ID: 3756899)
1. Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancer.
Chodak GW; Shing Y; Borge M; Judge SM; Klagsbrun M
Cancer Res; 1986 Nov; 46(11):5507-10. PubMed ID: 3756899
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer.
Chodak GW; Hospelhorn V; Judge SM; Mayforth R; Koeppen H; Sasse J
Cancer Res; 1988 Apr; 48(8):2083-8. PubMed ID: 3349479
[TBL] [Abstract][Full Text] [Related]
3. Heparin binding affinity of rat prostatic growth factor in normal and cancerous prostates: partial purification and characterization of rat prostatic growth factor in the Dunning tumor.
Matuo Y; Nishi N; Matsui S; Sandberg AA; Isaacs JT; Wada F
Cancer Res; 1987 Jan; 47(1):188-92. PubMed ID: 3791206
[TBL] [Abstract][Full Text] [Related]
4. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
Hudgins WR; Orth DN; Stromberg K
Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897
[TBL] [Abstract][Full Text] [Related]
5. Human endothelial cell growth factors derived from thyroid anaplastic cell carcinoma.
Itoh K; Fukuda K; Matsuzaki T; Takao S; Ohyama M
Laryngoscope; 1989 May; 99(5):533-7. PubMed ID: 2651830
[TBL] [Abstract][Full Text] [Related]
6. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
Roberts WG; Hasan T
Cancer Res; 1993 Jan; 53(1):153-7. PubMed ID: 8416739
[TBL] [Abstract][Full Text] [Related]
7. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice.
Twardzik DR; Kimball ES; Sherwin SA; Ranchalis JE; Todaro GJ
Cancer Res; 1985 May; 45(5):1934-9. PubMed ID: 3872712
[TBL] [Abstract][Full Text] [Related]
8. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
[TBL] [Abstract][Full Text] [Related]
10. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions.
Yura Y; Hayashi O; Kelly M; Oyasu R
Cancer Res; 1989 Mar; 49(6):1548-53. PubMed ID: 2784351
[TBL] [Abstract][Full Text] [Related]
11. Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.
Chai TC; Zhang CO; Shoenfelt JL; Johnson HW; Warren JW; Keay S
J Urol; 2000 May; 163(5):1440-4. PubMed ID: 10751853
[TBL] [Abstract][Full Text] [Related]
12. A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients.
Eckert K; Granetzny A; Fischer J; Nexø E; Grosse R
Cancer Res; 1990 Feb; 50(3):642-7. PubMed ID: 2297705
[TBL] [Abstract][Full Text] [Related]
13. Transferrin as a growth factor for rat bladder carcinoma cells in culture.
Hayashi O; Noguchi S; Oyasu R
Cancer Res; 1987 Sep; 47(17):4560-4. PubMed ID: 3621154
[TBL] [Abstract][Full Text] [Related]
14. HIV-tat protein is a heparin-binding angiogenic growth factor.
Albini A; Benelli R; Presta M; Rusnati M; Ziche M; Rubartelli A; Paglialunga G; Bussolino F; Noonan D
Oncogene; 1996 Jan; 12(2):289-97. PubMed ID: 8570206
[TBL] [Abstract][Full Text] [Related]
15. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
16. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
[TBL] [Abstract][Full Text] [Related]
17. An angiogenic factor from human bladder cancer: the investigation of purification and biological activities.
Chen BQ; Yu MS; Shao GX; Chen BF
Chin Med J (Engl); 1993 Jul; 106(7):489-93. PubMed ID: 7694825
[TBL] [Abstract][Full Text] [Related]
18. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic effects of platelet-derived growth factor, fibroblast growth factor, transforming growth factor-beta, and heparin-binding serum factor for adult mouse Schwann cells.
Watabe K; Fukuda T; Tanaka J; Toyohara K; Sakai O
J Neurosci Res; 1994 Dec; 39(5):525-34. PubMed ID: 7891388
[TBL] [Abstract][Full Text] [Related]
20. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor.
Shing Y; Folkman J; Sullivan R; Butterfield C; Murray J; Klagsbrun M
Science; 1984 Mar; 223(4642):1296-9. PubMed ID: 6199844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
